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Abstract Several studies have suggested that extracellular
vesicles (EVs) released from mesenchymal stem cells
(MSCs) may mediate MSC paracrine action on kidney regen-
eration. This activity has been, at least in part, ascribed to the
transfer of proteins/transcription factors and different RNA
species. Information on the RNA/protein content of different
MSC EV subpopulations and the correlation with their bio-
logical activity is currently incomplete. The aim of this study
was to evaluate the molecular composition and the functional
properties on renal target cells of MSC EV sub-populations
separated by gradient floatation. The results demonstrated het-
erogeneity in quantity and composition of MSC EVs. Two
peaks of diameter were observed (90–110 and 170–190 nm).
The distribution of exosomal markers and miRNAs evaluated
in the twelve gradient fractions showed an enrichment in frac-
tions with a flotation density of 1.08–1.14 g/mL. Based on this
observation, we evaluated the biological activity on renal cell
proliferation and apoptosis resistance of low (CF1), medium
(CF2) and high (CF3) floatation density fractions. EVs de-
rived from all fractions, were internalized by renal cells,
CF1 and CF2 but not CF3 fraction stimulated signifi-
cant cell proliferation. CF2 also inhibited apoptosis on
renal tubular cells submitted to ischemia-reperfusion in-
jury. Comparative miRNomic and proteomic profiles
reveal a cluster of miRNAs and proteins common to
all three fractions and an enrichment of selected mole-
cules related to renal regeneration in CF2 fraction. In conclu-
sion, the CF2 fraction enriched in exosomal markers was the
most active on renal tubular cell proliferation and protection
from apoptosis.
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regeneration
Introduction
Extracellular vesicles (EVs) are small extracellular membrane
fragments heterogeneous for their origin, dimensions and con-
tent. EVs are mainly composed by exosomes, small homoge-
neous vesicles (50–150 nm) formed from the endosomal cell
compartment, and by microvesicles, with a more heteroge-
neous dimension profile, produced by the direct extrusion of
the cell plasma membrane. Ratajczak et al. [1] first demon-
strated that embryonic stem cells may release EVs capable to
reprogram hematopoietic progenitors. EVs derived from adult
stem/progenitor cells have been described to retain features
resembling their cells of origin. In particular, EVs derived
from mesenchymal stem cells (MSCs) can mediate the para-
crine effects of MSCs in different models of tissue regenera-
tion [2–5]. Selective molecules such as proteins, RNAs and
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small non coding RNAs are compartmentalized inside EVs [1,
6–10], and may be transferred to target cells via EVs.
Numerous studies reported the heterogeneity in EV popula-
tions. Exosomes showed the presence of subsets of cellular
proteins, such as the tetraspanin family members (CD63,
CD81 and CD9), heat-shock proteins [11], and endosomal
sorting complexes proteins, such as Alix and TSG101 [12].
Moreover, specific subsets of small RNAs have been de-
scribed as selectively incorporated in different EV populations
[13, 14]. Functional studies have been usually performed
using a heterogeneous EV combination or selective sub-
fractions [15, 16]. Numerous protocols to isolate EV sub-
populations have been described [17], but to identify a method
to separate a pure population still remains challenging [18].
EVs from MSCs (MSC EVs) have been extensively used for
the treatment of acute kidney injury (AKI), showing regener-
ative properties. These were ascribed, at least in part, to the
transfer of RNA species, such as mRNAs and miRNAs [2, 8,
19, 20]. Comprehensive information on the RNA/protein con-
tent of different subpopulation of MSC EVs is currently
incomplete.
The aim of this study was to analyze the composition and
activity of different EV sub-populations released fromMSCs,
defining the molecular profile associated with their activity on
renal tubular epithelial cells. For this purpose, we fractioned
by density gradient the conditioned medium (CM) of MSCs
and investigated the different EV subpopulations obtained.
Moreover, we combined different gradient fractions (CFs),
on the bases of differential expression of exosomal markers
and density, and then we characterized their biological activity
on renal target cells. The signaling pathway (s) associatedwith
the protein and miRNA cargo content of different EV subpop-




Bone marrow MSCs were purchased by Lonza (Basel,
Switzerland) and cultured as previously described [2]. Cells
were used within the seven passages. MSCs characterization
was performed by cytofluorimetric analysis for the expression
of the typical mesenchymal markers as described [2].
Murine tubular epithelial cells (mTEC) were isolated from
the kidneys of healthy C57 mice. Cells were cultured and
characterized as previously described by Bruno et al. [2].
mTEC were positive for classical epithelial markers such as:
cytokeratin, actin, alkaline phosphatase, aminopeptidase A,
and megalin, and negative for CD45, von Willebrand factor,
desmin and nephrin.
Preparation of Extracellular Vesicles-Containing
Conditioned Medium
For the preparation of the conditioned medium (CM), MSCs
(passage 3–7) were cultured in the presence of their expansion
medium until 80% of confluence. Conditioned medium was
obtained from supernatants of 8.95 ± 0.46 × 103/cm2 MSCs
maintained in RPMI medium supplemented with 0.1% BSA
for 16 h. The viability of MSCs after starvation was about
86 ± 0.5% as detected by the Muse® Count &Viability
Assay Kit (CTRL normal medium 88,9% of vitality)
(Millipore, MA, USA). Supernatant was first centrifuged at
1500 g for 20 min, to remove debris and apoptotic bodies and
then concentrated at 4 °C, approximately 200-fold, using ul-
trafiltration units (Amicon Ultra-PL 3,Millipore) with a 3 kDa
molecular weight cut-off as previous described [21]. After the
concentration CM-containing EVs in 1% dimethyl sulfoxide
was kept at −80 °C until use.
Density Gradient Separation of EVs
A discontinuous iodixanol gradient was prepared as described
by Tauro et al. [22]. Solutions of 5, 10, 20 and 40% iodixanol
were obtained by mixing an OptiPrepTM (60% w/v aqueous
iodixanol solution) (Sigma-Aldrich, St. Louis, MO) with the
appropriate amounts of homogenization buffer (0.25 M
sucrose/ 10 mM EDTA/ 10 mMTris-HCL, pH 7.4). The gra-
dient was formed by layering 3 ml of 40%, 3 ml of 20%, 3 ml
of 10% and 2.5 ml of 5% solutions in a 13 ml open top
polyallomer tube (Beckman Coulter). 500 μl of CM-
containing EVs (cCM-EVs) were overlaid onto the top of
the gradient [22] or at the bottom [23] and centrifuged for
18 h at 100,000 g at 4 °C (SW 40 Ti rotor, Beckman Coulter
Optima L-90 K ultracentrifuge, Indianapolis, IN). Preliminary
experiments demonstrated the same vesicles distribution using
the protocols listened above (not shown) and the loading from
the top of the gradient [22] was used in the following
experiments.
Twelve gradient fractions of 1 ml, were collected from the
top of the gradient, diluted with 10 ml PBS for washing and
centrifuged at 100,000 g for 2 h at 4 °C. The pellets were re-
suspended in 100 μl PBS or medium based on the following
use. The density of each fraction was measured by weighing a
fixed volume [16]. In some experiments, fractions were divid-
ed into three groups (combined fractions, CFs), based on their
density and on the expression of specific surface markers
(Fractions 1–4 low density, CF1; Fractions 5–8, medium den-
sity CF2; Fractions 9–12, high density CF3).
EV Incorporation
To trace EVs by fluorescence microscopy, MSCs were labeled
with Vybrant Cell Tracers Dil and Syto-RNA (Life
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Technologies, Carlsbad, CA) as previous described [20]. EVs
obtained from labeled cells were concentrated and subjected
to gradient separation as described above. For EV incorpora-
tion, mTEC were plated in 24-well plated and treated with
different doses of labeled cCM-EVs (50,000, 150,000,
300,000 or 600,000 EVs/cell) for 24 h. Quantitative analysis
of the EV uptake was conducted by FACS. To determine the
incorporation of each fraction, mTEC were seeded into 24-
well plates and incubated with labeled EVs (150,000 EVs/
cell) from the different combined fractions for 24 h. The up-
take of EVs was analyzed by microscope analysis using the
ApoTome system (Carl Zeiss, Oberkochen, Germany).
Hoechst 33,258 dye (Sigma-Aldrich) was added for nuclear
staining.
In Vitro Models
mTEC were seeded at 1500 cells/well into 96-well plates and
cultured in serum free low-glucose DMEM in the absence
(vehicle, CTR-) or presence of EVs (1 × 107 EVs/ml,
1 × 108 EVs/ml or 1 × 109 EVs/ml). Cells maintained in
low-glucose DMEM (Sigma-Aldrich) plus 10% FCS were
used as positive control (CTR+). In selected experiments, to
mimic the ischemia damage on renal cells, mTEC cultured in
serum free DMEMwere placed in hypoxic chambers with 1%
O2 for 48 h. The re-oxygenation step was conducted for 24 h,
in the absence (vehicle, HY/CTR-) or presence of EVs
(1 × 107 EVs/ml). DMEM plus 10% FCS (HY/CTR+) or
EGF (10 ng/ml, Sigma) (HY/EGF) in the re-oxygenation step
were used as controls. For cell proliferation, DNA synthesis
was detected as incorporation of 5-bromo-2′-deoxy-uridine
(BrdU) into the cellular DNA at 48 h (Roche Applied
Science, Mannheim, Germany). Apoptosis/necrosis was mea-
sured by Muse™ Caspase-3/7 Kit (Millipore) following the
instructions. Percentage for live, apoptotic, and necrotic cells
was measured.
EV Characterization
Gradient isolated EVs were analyzed by nanoparticle tracking
analysis (NTA), using the NanoSight LM10 system
(NanoSight Ltd., Amesbury, UK), equipped with a 405 nm
laser and with the NTA 2.3 analytic software, to define their
dimension and profile. Camera levels were for all the acquisi-
tion at 16 and for each sample, five videos of 30 s duration
were recorded. Briefly, cCM-EVs or gradient-separated EVs
were diluted (1: 1000 and 1: 10, respectively) in 1 ml vesicle-
free physiologic solution (Fresenius Kabi, Runcorn, UK).
NTA post-acquisition settings were optimized and maintained
constant among fractions, and each video was then analyzed
to measure EV mean, distribution and concentration.
EVs from the twelve fractions were characterized by
cytofluorimetric analysis using the Guava easyCyte Flow
Cytometer (Millipore) with InCyte software. The following
FITC or APC conjugated antibodies were used: CD107,
CD81 and CD63. FITC or APC mouse non-immune isotypic
IgG (Miltenyi Biotec, Bergisch Gladbach, Germany) were
used as controls as previously described [20]. Briefly, imme-
diately after labelling for 15 min at 4 °C with antibodies, EVs
(1.5 × 108 particles) diluted 1 to 3 were acquired.
Western Blot Analysis
For protein analysis, EVs from different fractions and MSCs
were lysed at 4 °C for 30min in RIPA buffer (20 nMTris-HCl,
150 nM NaCl, 1% deoxycholate, 0.1% SDS, 1% Triton
X-100, pH 7.8) supplemented with protease and phosphatase
inhibitors cocktail (Sigma-Aldrich). Protein content in EV
fractions were quantified by BCA Protein Assay Kit (Pierce,
Thermo Fisher Scientific, Waltham, MA). Ten μg of proteins
were then separated by 4% to 15% gradient sodium dodecyl
sulfate–polyacrylamide gel electrophoresis. The proteins were
transferred onto a PVDF membrane by the iBlot™ Dry
Blotting System (Life Technology) and then immunoblotted
with the following antibodies: CD63 andANXA2 (Santa Cruz
Biotechnology, Santa Cruz CA), HLA1 (Abcam, Cambridge,
United Kingdom), CD29 (Thermo Fisher Scientific) and
Integrin alpha-5 (Millipore). The protein bands were visual-
ized using a ChemiDoc™ XRS + (BioRad) with an enhanced
chemiluminescence detection kit (ECL) (GE healthcare,
Amersham, Buckinghamshire, UK).
Electron Microscopy
Transmission electron microscopy of EVs was performed by
loading EVs from different CF onto 200 mesh nickel formvar
carbon coated grids (Electron Microscopy Science, Hatfield,
PA) for 20 min. EVs were then fixed with a solution contain-
ing 2.5% glutaraldehyde and 2% sucrose and after repeated
washings in distilled water, samples were negatively stained
with NanoVan (Nanoprobes, Yaphank, NK, USA) and exam-
ined by Jeol JEM 1010 electron microscope.
RNA Isolation
Total RNAwas isolated from gradient separated EVs using the
mirVana RNA isolation kit (Applied Biosystem) according to
the manufacturer’s protocol. RNA from all the twelve fractions
or from the three CFs was quantified (Nanodrop ND-1000,
Wilmington DE) and the small RNA composition of different
CFs was assessed by capillary electrophoresis on an Agilent
2100 Bioanalyzer using the small RNAs kit (Agilent
Technologies, Inc., Santa Clara, CA).
228 Stem Cell Rev and Rep (2017) 13:226–243
miRNA Screening
Purified CF-derived EVs isolated from three different MSCs
preparations were analyzed for their miRNA content by quan-
titative real time (qRT) PCR using the Applied Biosystems
TaqManH MicroRNA Assay Human Panel Early Access kit
(Life Technologies), able to profile 754 human mature
miRNAs by sequential steps of reverse transcription
(Megaplex RT Pools; Life Technologies) using an Applied
Biosystems 7900H qRT-PCR instrument as previously de-
scribed [20]. Briefly, single stranded cDNA was generated
from total RNA sample (80 ng) by reverse transcription using
a mixture of looped primers (Megaplex RT kit, Life
Technologies) following manufacturer’s protocol. The pre-
amplification reaction for each sample was performed using
a TaqMan® PreAmp Master Mix 2X (Life Technologies)
mixed with specific Megaplex™ PreAmp Primers (10X)
(Life Technologies). Pre-amplified products were then diluted,
loaded in the TaqManMicroRNAArray and qRT-PCR exper-
iments were performed.
Raw Ct values, automatic baseline and threshold were cal-
culated using the SDS software version 2.3. Comparison of
miRNA expression was conducted using the Expression Suite
software (Life Technologies). Fold change (Rq) in miRNA
expression among the three fractions was calculated as
2-ΔΔCt using one of the fraction (CF2) as control and normal-
izing the data using global normalization [24]. Confirmation
of the expression of specific miRNAs in the three fractions
was conducted using the miScript SYBR Green PCR Kit
(Qiagen, Valencia, CA, USA). Briefly, 50 ng of input RNA
were reverse transcribed using the miScript Reverse
Transcription Kit and the cDNAwas then used to detect and
quantify miRNAs of interest. Experiments were run in tripli-
cate using 3 ng of cDNA for each reaction as described by the
manufacturer’s protocol (Qiagen). The following miRNAs
were screened in all the CF: miR-100, miR-21, miR-24,
miR-214, miR-34a, miR-127, miR-30c, miR-29a, miR-
125b, miR-10b, let-7c, miR-99a, miR-17 and miR-20a.
Analysis of miR-451 distribution in the twelve fractions
was carried on using the miRCURY LNA™ Universal RT
microRNA PCR kit (Exiqon, A/S, Vedbaek, Denmark). Fifty
pg of reverse transcription reaction products were then com-
bined with SYBR Green Master Mix (Exiqon) and LNA™
PCR primer mix and analyzed as described by the manufac-
turer’s protocol. All the qRT-PCR data were normalized using
the UniSp6 and the UniSp2 RNA Spike-in templates respec-
tively as cDNA synthesis and RNA extraction controls
(Exiqon).
Protein Array
Purified CF-derived EVs isolated from different MSC prep-
arations were lysed in 2× Cell Lysis Buffer (RayBiotech, Inc.,
GA), and 15μg of EV proteins from all the CFs, were used for
RayBio Label-based (L-Series) Human Antibody Array 1000
(RayBiotech) according to the manufacturer instructions. The
arrays were performed in duplicates, using a pull of EVs de-
rived from two different MSC preparations/array. The array
provides detection of 1000 proteins.
Data analysis was conducted after background signal sub-
traction and normalization to positive controls (Mean back-
ground +4 standard deviations, accuracy ≈ 99%). Comparison
of signal intensities among array images was used to define
relative differences in expression levels of each protein among
the CF fractions. Differential expression analysis was con-
ducted using CF2 as reference fraction. Proteins were consid-
ered co-expressed when they showed a Fold change
(FC) = 0.65 ≤ FC ≤ 1.5 in all sample tested. Differential ex-
pression among CFs was considered when FC distribution:
<0.65 or >1.5 in all the sample tested.
Pathway and Gene Ontology Analysis of EV Content
For CF2 miRNA target prediction and biological pathway
enrichment analysis, the web-based program DIANA-
mirPath [25] was used. The algorithm microT-CDS was cho-
sen to predict EV-derivedmiRNA targets using default thresh-
old (microT = 0.8). Only biological pathways showing P
value < 0.01 to all known Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathways were considered as signifi-
cantly enriched.
For protein class analysis and pathway classification
Panther classification system was used (http://pantherdb.
org/). Gene Ontology (GO) analysis was conducted using
David functional annotation tool (http://david-d.ncifcrf.gov.).
Functional sorting of the proteins differentially expressed
between CF2 and the other fractions was done using Funrich
analysis tool [26].
Statistical Analysis
Data were analyzed using the GraphPad Prism 6.0
Demo program. Statistical analyses were conducted
using One-way ANOVA with Dunnett’s or Turkey’s
post-tests, where appropriated. Statistical significance
was established at P < 0.05.
Results
Heterogeneity of EVs Released from MSCs.
To isolate a total EV population from MSCs, we pre-purified
their CM as described in Material and Methods. The CM was
then subjected to concentration and the number of isolated
EVs was counted byNTA.We observed that themean number
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of EVs present in the concentrated CM was around
12,750 ± 3187 particles/cell. The cCM-EVs represented a
mix population with different diameter, ranging from 50 to
390 nm (Fig. 1a). Two peaks of diameter were defined around
90–110 and 170–190 nm (Fig. 1a) with a mean diameter in the
total population of 136 ± 16 nm and a mode of
119 ± 21 nm. The identification of a heterogeneous
population prompts us to define its molecular content
and activity. For this purpose, we fractionated the cCM-EVs
by density gradient separation, isolating twelve different EV
fractions. Density of each fraction was measured by weighing
a fixed volume (Fig. 1b) [16]. The analysis of EV distribution
by NTA, showed an enrichment of vesicles in fractions 1, 4
and 8 (Fig. 1c).
Characterization of EVs in Different Fractions.
By FACS analysis the expression of CD63 endosome-derived
exosome marker was mainly observed in fractions 5–8, with a
flotation density of 1.08–1.14 g/mL (Fig. 2a). The other
tetraspanin family member, CD81 and the lysosomal-
associated membrane protein 1, CD107, showed almost the
same sinusoidal pattern (Fig. 2a). As shown in Fig. 2b, the
biological activity on mTEC is widely distributed in different
fractions, except for the densest fractions, but is significantly
higher in fraction 6.
Total RNAwas extracted from all the twelve fractions and
the major concentration of RNAwas isolated from fractions 5,
8, 9 and 11 (not shown). Since it has been suggested a selec-
tive export of specific miRNAs from different cell compart-
ments [10], we evaluated the distribution of a group of
miRNAs that we previously described in MSC-derived EVs
[8]. miR-21 was expressed in almost all the EV fractions.
However, as shown in Fig. 2c, the Raw Ct of miR-21 indicat-
ed its enrichment in the central fractions (Fig. 2c). Similar
enrichment pattern was observed for miR-100, −99a and
−24 (data not shown). Conversely, miR-451was detected only
in central fractions enriched in the tetraspanin family markers
(Fig. 2C) and this distribution was compatible with the
exosomal derivation of this miRNA. To exclude the possibil-
ity of confounding technical factors on the obtained results,
we performed miR-451 quantification adding a synthetic
spike-in (UniSp6) during the cDNA synthesis. We obtained
the same results, demonstrating the effective compartmental-
ization of miR-451 mainly in the CD63 positive fractions
(Fig. 2d).
Biological Effect and Characterization of EV Combined
Fractions
In order to pair the biological activity with the molecular con-
tent of the EV subpopulations, we combined the gradient frac-
tions into three groups (Fractions 1–4, low density CF1;
Fractions 5–8, medium density CF2; Fractions 9–12, high
density CF3), based on their density and on the expression
of exosome surface markers and miRNAs. We first analyzed
the up-take of labelled cCM-EVs by mTEC. Figure 3a shows
a dose dependent up-take of cCM-EVs. We then tested the
uptake of EVs from the different fractions using confocal mi-
croscopy (Fig. 3b-d). Using EVs labelled with Vybrant Dil
and with Syto-RNA, we observed the concomitant presence
within the cells of the two dyes, suggesting the EV delivery of
RNAs inside mTEC.
To discriminate the effects of the different EV fractions on
cell proliferation and apoptosis, in vitro experiments were per-
formed. Despite all EV fractions slightly promoted cell prolif-
eration on mTEC, only the low density CF1 and medium
density CF2 fractions induced a statistically significant
Fig. 1 Characterization of EVs isolated from the conditioned medium
(CM) of human MSCs and subjected to OptiPrep gradient separation. a
Nanoparticle Tracking Analysis (NTA) profiles of particle size and
distribution of EVs present in the concentrated CM of MSCs (cCM-
EVs). cCM-EVs represent a extracellular vesicle population containing
exosomes andmicrovesicles. Two peaks around 90–110 and 170–190 nm
were detected. bWeight of the twelve different EV fractions generated by
gradient separation of cCM-EVs. c NTA analysis of the percentage of
EVs distributed in different fractions after gradient separation. Data
reported are mean ± SEM of four different experiments
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proliferation at 1 × 108 and 1 × 109 particles/ml concentration
(Fig. 3e). We next evaluated the effects of the combined frac-
tions in a hypoxia/reperfusion model that mimics renal tubule
damage during the ischemia reperfusion injury (IRI). For this
purpose, mTEC were treated with CFs during the re-
oxygenation phase of IRI. Only the CF2 medium-density ves-
icles together with the EGF treatment during the reperfusion
phase were anti-apoptotic (Fig. 3f). On the contrary, CF1 low-
density vesicles or CF3 high density EVs were not significant-
ly protective on mTEC submitted to IRI.
To define the molecular composition of the EV gradient
fractions, accountable for their different biological potential,
further characterization studies were conducted. Transmission
electron microscopy analysis performed on purified EVs
showed their spheroid morphology (Fig. 4a). The size of
EVs present in CF1 was more heterogeneous of the CF2 ones.
NTA quantification of the particle distribution among the CF
demonstrated an enrichment of vesicles in CF1 and CF2 in
respect to CF3 fraction (Fig. 4b). As shown in Fig. 4c, NTA
measure of the percentage of size distribution indicated that
Fig. 2 Characterization of specific exosome markers and activity of the
twelve EV fractions isolated by gradient separation. a FACS analysis of
the expression of the tetraspanin members, CD63 and CD81 and the
lysosomal-associated protein, CD107 in different EV fractions. The
exosome markers showed a relevant co-localization in fractions 5–8,
characterized by a flotation density of 1.08–1.14 g/mL. b Evaluation of
the effects of different EV fractions on mTEC proliferation after 48 h of
stimulation, assessed by BrdU up-take (1 × 107 EVs/ml) in respect to
control cells (CTR-, DMEM no FCS). Cells cultured in DMEM plus
10% FCS were used as positive control (CTR + =1). Data are expressed
as Ratio means ±SEM. ANOVA with Dunnett’s multicomparison test.
*P < 0.05 vs CTR-. c Representive qRT-PCR expression of miR-21 and
miR-451 in the twelve fractions. Raw data analysis of miR-21( )
shows its expression in almost all the EV fractions. On the contrary, miR-
451 ( ) shows selective compartmentalization in the central fractions.
d Representative qRT-PCR analysis showing the relative quantity of miR-
451 in respect to the synthetic spike-in (UniSp6) used as normalizer.
Normalized data showed the distribution of miR-451 inside the exosome-
enriched EV fractions. Three experiments were conducted with similar
results
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CF1 and CF2 contain smaller EVs (50–150 nm) whereas the
CF3 is also enriched in EVs of larger size (>200 nm). The
mean diameter of the different populations was respectively:
134.7 ± 19,7 for CF1, 147 ± 27,5 for CF2 and 169 ± 39 for
CF3 (Fig. 4c, lower panel).
The expression of some classical vesicular markers (CD63,
ANXA2 and CD29) was compared among the three CFs and
their cells of origin by Western blot analysis (Fig. 4d-e). The
integrin alpha-5 andHLA-1were also screened in the different
fractions (Fig. 4e). CD63 was almost absent in low-density
vesicles of CF1, being enriched in the medium-density EVs of
CF2 fraction and into a lesser extent in the high-density CF3
fraction (Fig. 4d). The integrin β1 (CD29), showed the same
distribution of the tetraspanin CD63, being enriched in CF2
and CF3 and expressed at low levels in CF1 fraction (Fig. 4e).
ANXA2, involved in recruitment of miRNAs in EVs, resulted
mainly present in fraction CF2 and CF3 (Fig. 4e), supporting
the relevant enrichment of miRNAs detected in these two
fractions (Fig. 4f). The HLA-class I and α5-integrin
(ITGA5) were selectively expressed by the medium-density
fraction CF2 (exosome enriched fraction) and almost absent in
CF1 low-density fraction (Fig. 4e). Low expression of these
two markers was observed in the CF3 high-density fraction
(microvesicle enriched fraction).
miRNA Compartmentalization inside CF Fractions
RNA was extracted by different CFs and spectrometrically
quantified. The bioanalyzer profile showed the enrichment
of RNA of the size of miRNAs in the medium-density CF2
and high-density CF3 fractions (Fig. 4f). No relevant differ-
ences in the total RNA isolated in respect to the EV quantity
among the three CFs was observed (CF1: 2.62 ± 0.97, CF2:
2.75 ± 0.78, CF3: 2.94 ± 0.88 × 10−9 ng/particle) (Fig. 5a).
The expression of 754 human miRNAs was measured by
qRT-PCR. Analyzing the normalized Cycle threshold distri-
bution (ΔCt, based on Median calculation) of all expressed
miRNAs (Ct < 40), the medium-density EVs of CF2
fraction showed a low correlation with both CF3 and
CF1 EV populations (Pearson correlation: 0.50 and
0.69, respectively) (Fig. 5b).
Fig. 3 Activity of the combined gradient fractions on tubular cell
proliferation and apoptosis. a Quantitative FACS analysis of the up-take
of labelled cCM-EVs by mTEC. A dose dependent up-take of cCM-EVs
(50,000–600,000 EVs/cell) was observed after incubation for 24 h. b-d
Representative micrograph of the internalization of EVs from CF1 (b),
CF2 (c) and CF3 (d) by mTEC after 24 h, observed by confocal
microscopy. EVs were collected from MSCs double-stained with Syto-
RNA (green) and Vybrant Dil (red). Three experiments were performed
with similar results. Nuclei were counterstained with Hoechst dye.
Original magnification: ×630. (E-F) Evaluation of the effects of the
combined fractions on mTEC proliferation (e) and protection from
apoptosis (f). e Absorbance ratio of the BrdU up-take by mTEC
incubated for 48 h with EVs from different CFs (1 × 107 EVs/ml,
1 × 108 EVs/ml or 1 × 109 EVs/ml) in respect to control cells (CTR-,
DMEM no FCS). Cells cultured in DMEM plus 10% FCS were used as
positive control (CTR+). f Cell death analysis on mTEC subjected to
hypoxia/reperfusion was measured by Muse™ Caspase-3/7 Kit. Cells
were subjected to hypoxia for 48 h, then EVs from CFs were added
during the 24 h of reperfusion (1 × 107 EVs/ml). Cells maintained in
the absence of serum were used as negative control (HY/CTR-). Cells
cultured in DMEM plus 10% FCS in the reperfusion phase were used as
positive control (HY/CTR+). Black bars indicate apoptosis and grey bars
represent necrosis. Data are expressed as means ±SEM. ANOVA with
Dunnett’s multicomparison test. *P < 0.05, **P < 0.01, ***P < 0.001
vs CTR- or HYP/CTR-, respectively
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Using a cut-off ≤35 Ct value in miRNA expression, we
found 162 miRNAs present in all the EV fractions (Fig. 5c;
Table 1). The analysis showed a selective package of miRNA
subsets in medium-density CF2 EV fraction which were unde-
tected in the other fractions (Table 2) (Fig. 5c). Among these
miRNAs, we observed 19 miRNA* sequences detected only
in the CF2 fraction, as previously described for tumor derived
exosome population [14].
By analyzing the fold change distribution of the co-
expressed miRNAs among all the fractions (miRNA intersec-
tion), we observed a relevant enrichment of miRNAs in CF2
fraction containing exosome enriched-EVs. Among the 162
miRNAs expressed by all the fractions, we found that 112
miRNAs were significantly up-regulated in the CF2 fraction
in respect to CF1 (Fig. 5d) and only 12 miRNAs were down-
regulated. The same trend was observed between CF2 and
CF3 (89 miRNAs up-regulated and 15 down-regulated in
CF2 in respect to CF3) (Fig. 5e).
In CF2,we detected 106miRNA families with an enrichment
of the following families: miR-10, miR-17, miR-154, miR-30,
miR-27, miR-15, let-7, miR-379, miR-26, miR-34 and miR-
548 families (not shown).
We confirmed by qRT-PCR the compartmentalization of
miRNAs highly enriched in MSC EVs and/or connected with
kidney regeneration in the CF2 fraction (miR-100, −21, −24,
−214, −34a, −127, −30c, −29a, −125b, −10b, −let-7c, −99a,
−17 and miR-20a) [8, 27–32] (Fig. 5f). Some miRNAs, such
as miR-21, −24, −214, and −17 were also enriched in the
dense fraction CF3, possiblly being a common signature of
different EV sub-fractions. Reduced miRNA content was de-
tected in the low-density EV CF1 fraction (Fig. 5f).
Analysis of the pathways over-represented by the predicted
targets of enriched/selective CF2 miRNAs was performed
with the DIANA mirPath software, as previously described
[33]. We detected an enrichment of 14 KEGG biological pro-
cesses for the CF2 enrichedmiRNAs and 11 KEGG processed
for the CF2 selective miRNAs (P < 0.01, FDR corrected) (S1
Table and S2 Table). Sixty-nine miRNAs from the two groups
showed strong correlation with the same pathways assembled
in metabolic, stem cell associated- and migration/
inflammation processes.
The following metabolic-related pathways were over-rep-
resented: fatty acid biosynthesis and metabolism, biosynthesis
of unsaturated fatty acids, mucin type O-glycan biosynthesis
Fig. 4 Characterization of morphology, protein surface and miRNA
content of combined fraction EVs. a Transmission electron microscopy
(original magnification × 75,000) of EVs from different CFs. All the CFs
contain vesicles with a typical cup-shaped morphology (scale bar
100 nm). Particles with a different electron density were observed in the
CF3 fraction. b Percentage of EVs isolated for each combined fraction
detected by NTA. The CF3 resulted the fraction with less EVs in respect
to the low-density CF1 and medium-density CF2 fractions. c Percentage
of size distribution of EVs in different CF fractions measured by NTA
(upper panel). The mean diameter (nm) of each CF populations was also
measured (lower panel). Four different gradients were tested in triplicate.
(d-e) Representative Western blot analysis of CD63 (d), integrin β1
(CD29), α5-integrin (ITGA5), annexin A2 (ANXA2) and HLA-class I
(e) on MSCs and CF derived EVs. Three different experiments were
performed with similar results. (f) Representative bioanalyzer profile of
small RNAs performed on EVs from the CFs, showing a relevant
enrichment of total miRNAs in the medium density CF2 and high
density CF3 fractions in respect to CF1. Three different samples tested
in triplicate with similar results
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and lysine degradation (Table 3). Pathways related to stem
cells were: Hippo signaling, Wnt signaling and pluripotent
stem cells regulated-pathways (Table 3). Migration-
inflammation related processes such as ECM-receptor interac-
tion, TGF-β signaling pathway, glioma and proteoglycans in
cancer were also over-represented (Table 3). Heatmap repre-
sentation of the most significantly enriched pathways poten-
tially modulated by the 69 miRNAs is shown in Fig. 6.
Protein Characterization in CF Fractions.
Protein composition of different CFs could also define their
origin and activity. For this reason, proteins were isolated from
the three CFs and quantitative proteomic analysis of 1000
proteins was then conducted. Raw data was reported as sup-
plementary information (S3 Table). We observed first a differ-
ent distribution of total proteins among the three fractions with
an enrichment of isolated proteins in respect to the EV quan-
tity in CF3 high-density fraction (Fig. 7a). Less amount of
proteins was isolated in CF1 in respect to the high quantity
of EVs detected in this fraction.
Proteomic profile of all CFs showed the presence of 655
proteins in the CF2 fraction over the 1000 analyzed. 435 pro-
teins were compartmentalized in the CF3 high-density frac-
tion and 581 in the CF1 low-density fraction. A group of 413
proteins was detected in all the EV populations. Panther
Fig. 5 Analysis ofmiRNA compartmentalization inside the CF fractions.
a Quantification of the total RNA isolated from the different CFs. Data
are expressed as means ±SEM (ng RNA/EV) of four different
experiments. No significant differences were observed among the three
fractions. (b-e) qRT-PCR profile of 754 mature miRNAs in the CF
fractions. b Scatter plot of normalized Cycle threshold distribution
(ΔCt) of all expressed miRNAs (Ct < 40) between CF2 and the other
fractions. Pearson correlation was calculated (CF2 vs CF3: 0.50 and vs
CF1: 0.69). c Venn diagram showing the miRNAs present in all the EV
fractions (n = 162). A subset of miRNAs was specific of the medium-
density CF2 EVs and undetected in the others. Fold change distribution of
the co-expressed miRNAs (miRNA intersection) between CF1 and CF2
fractions (d) and between CF3 and CF2 fractions (e), showing a general
enrichment of miRNAs in fraction CF2. (f) Validation of the different
compartmentalization of specific miRNAs in CFs. The expression of
miRNAs enriched in MSC EVs and/or connected with kidney regenera-
tion was analyzed by qRT-PCR. All the miRNAs tested were reduced in
CF1, demonstrating less ability of this fraction to compartmentalize
miRNAs. The relative quantity of eachmiRNA (RQ)was measured using
the synthetic spike-in (UniSp2) as normalizer. Three different samples
tested in triplicate with similar results. Data are expressed as means
±SEM. ANOVAwith Dunnett’s multicomparison test. *P < 0.05 vs CF2
234 Stem Cell Rev and Rep (2017) 13:226–243
Table 1 List of the miRNAs detected in all the CF fractions. The miRNAs confirmed by qRT-PCR were labeled in red
List of miRNAs present in all the CFs  
hsa-miR-1243 hsa-miR-20a hsa-miR-15b hsa-miR-323-3p
hsa-miR-15a hsa-miR-886-5p hsa-miR-27b hsa-miR-532-3p
hsa-miR-1274B hsa-miR-376c hsa-miR-25 hsa-miR-29b
hsa-miR-302c hsa-miR-92a hsa-miR-218 hsa-miR-214#
hsa-miR-1274A hsa-miR-106b hsa-miR-766 hsa-miR-151-3p
hsa-miR-720 hsa-miR-30e-3p hsa-miR-34a hsa-miR-320B
hsa-miR-24 hsa-miR-26a hsa-miR-532 hsa-miR-324-3p
hsa-miR-99a hsa-miR-152 hsa-miR-625# hsa-miR-125b-1#
hsa-miR-100 hsa-miR-1260 hsa-let-7g hsa-miR-410
hsa-miR-19b hsa-miR-31# hsa-miR-539 hsa-miR-629
hsa-miR-125b hsa-miR-382 hsa-miR-133a hsa-miR-126#
hsa-miR-367 hsa-miR-335 hsa-miR-146a hsa-miR-571
hsa-miR-191 hsa-miR-365 hsa-miR-345 hsa-miR-142-3p
hsa-miR-21 hsa-miR-127 hsa-miR-130a hsa-miR-22#
hsa-miR-214 hsa-miR-132 hsa-miR-195 hsa-miR-148b
hsa-miR-574-3p hsa-miR-331 hsa-miR-411 hsa-miR-139-5p
hsa-miR-193b hsa-miR-328 hsa-miR-148a hsa-miR-505#
hsa-miR-197 hsa-miR-181a hsa-miR-126 hsa-miR-302a
hsa-miR-29a hsa-miR-222# hsa-miR-483-5p hsa-miR-362
hsa-miR-16 hsa-miR-1290 mmu-miR-374-5p hsa-miR-136#
hsa-miR-31 hsa-miR-224 hsa-miR-30d hsa-miR-128a
hsa-miR-409-3p hsa-miR-125a-5p hsa-miR-590-5p hsa-miR-27a#
hsa-miR-30c hsa-miR-28-3p hsa-miR-26b hsa-miR-199a
hsa-let-7e mmu-miR-140 hsa-miR-1271 hsa-miR-655
hsa-miR-145 rno-miR-7# hsa-miR-660 hsa-miR-885-5p
hsa-miR-320 hsa-miR-27a hsa-miR-34b hsa-miR-455
hsa-miR-17 hsa-miR-374 hsa-miR-20b hsa-miR-423-5p
hsa-miR-484 hsa-miR-212 hsa-miR-196b hsa-miR-638
hsa-miR-221 hsa-miR-10a hsa-miR-93# hsa-miR-889
hsa-miR-30b hsa-miR-143 hsa-miR-339-3p hsa-miR-204
hsa-miR-199a-3p hsa-miR-425-5p hsa-miR-432 hsa-miR-576-3p
hsa-miR-10b mmu-miR-93 hsa-miR-335# hsa-miR-193a-3p
hsa-miR-106a hsa-miR-34a# hsa-miR-494 hsa-miR-19b-1#
hsa-miR-422a hsa-miR-486 hsa-miR-296 hsa-miR-628-3p
hsa-miR-138 hsa-miR-150 hsa-miR-193b# hsa-miR-409-5p
hsa-miR-657 hsa-miR-10b# mmu-miR-137 hsa-miR-202
hsa-let-7b mmu-miR-134 hsa-miR-28 hsa-miR-203
hsa-miR-99b hsa-miR-146b hsa-miR-130b hsa-miR-572
hsa-miR-886-3p hsa-miR-193a-5p hsa-miR-744 hsa-miR-338-5P
hsa-miR-30a-3p hsa-miR-376a hsa-miR-301
hsa-miR-30a-5p hsa-let-7c mmu-miR-495
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pathway analysis on the CF proteome (413 proteins) found
high representation of the following pathways: interleukin
mediated signaling, inflammation mediated by chemokine
and cytokine, TGF-β signaling, gonadotropin release hor-
mone receptor, angiogenesis and Wnt signaling pathways
(Fig. 7b). CFs contained proteins which originate from differ-
ent cellular compartments such as extracellular region, plasma
membrane, extracellular matrix, vesicle lumen and secretory
granules (Table 4). Moreover, proteins of the CF proteome
were mainly incorporated in the following classes: signaling
molecules, receptors, defense/immunity proteins, enzyme
modulators and cell adhesion molecules (Fig. 7c). The top
ten GO biological processes overrepresented by the CF prote-
ome were mainly associated with regulation of cell prolifera-
tion, response to wounding, enzyme linked receptor protein
signaling pathway, inflammatory response, receptor linked
signal transduction, immune response and regulation of phos-
phorylation (Fig. 7d).
Differential expression analysis reveals that of the 655 pro-
teins expressed in the medium-density EVs fromCF2 fraction,
75 proteins were significantly up-regulated in respect to CF3
and 92 proteins resulted up-regulated in respect to CF1
(Table 5). Of them, 27 were commonly down-regulated in
both fractions. Selective proteins were up-regulated in CF1
and CF3 in respect to CF2 fractions (FC CF2 < 0.65) (CF1:
TGFBR2 and SFRP1 and CF3: NTRK2, EPHA5, SRMS, LTK,
TNFRSF1B, TGFBR1).
To investigate the differences at biological levels among
fractions, we performed functional enrichment analyses of
the proteins upregulated in CF2 in respect to CF3 and CF1.
Enriched GO molecular function (GO-MF) terms over-
represented by the proteins upregulated in CF2 in respect to
CF3, were mainly incorporated in: transmembrane receptor
and receptor-binding activities, G-protein couple receptor ac-
tivity, cytokine and hormone activities and cell adhesion mol-
ecules (Fig. 8a, outer chart). The GO-MF overrepresented for
proteins upregulated in CF2 in respect to the low-density frac-
tion CF1 were largely associated with cell adhesion mole-
cules, receptor binding and activity (Fig. 8a, inner chart).
Selective molecular functions were metallopeptidases and
protein tyrosine-kinase activity (Fig. 8a, inner chart).
Enriched GO biological processes (GO-BP) of proteins
upregulated in CF2 in respect to CF3 were chemotaxis, signal
transduction via receptor interaction, cell proliferation, re-
sponse to wounding, cell-cell signaling, development and in-
flammation (Fig. 8b). Enriched GO-BP were also observed,
for proteins down-regulated in CF1 in respect to CF2. These
include common processes such as signal transduction via
receptor interaction, cell proliferation, response to wounding
and cell-cell signaling. Selective processes such as cell adhe-
sion, regulation of cell differentiation and apoptosis were also
detected (Fig. 8c).
Discussion
The results of the present study demonstrated that EVs isolat-
ed from the conditioned medium of MSCs, using the gradient
separation technique, are heterogeneous in their quantity and
composition. Based on the differential expression of specific
exosome enriched-markers and different density among the
twelve fractions, we grouped them in three combined frac-
tions. The combined fractions, displayed differential pro-
proliferative and anti-apoptotic activities on renal tubular ep-
ithelial cells. Comparative miRNome and proteomic profiles,
revealed a cluster of miRNAs and proteins common to the
three vesicle fractions and fraction specific subsets of RNAs
and proteins.
EVs have been described as important players of the MSC
secretome. In fact, the beneficial effect of MSC treatment on
different models of acute and chronic damages was mimic by
a vesicles-based therapy [2, 16, 34–36]. EVs are composed of
several subpopulations and most of their characteristics are
not exclusive of a specific class of EVs [23]. For this reason,
the possibility that they act as distinct biological entities is
now under evaluation [37].
Table 2 List of the miRNAs selectively detected inside the CF2
fraction
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EVs released by MSCs, were a mixed population with dif-
ferent diameters and with two prominent peaks around 100 and
180 nm, as detected by NTA. EVs isolated by discontinuous
density gradient separation showed a heterogeneity in quantity
and expression of the classical exosomal markers. The
exosomal markers were mainly detected in the medium-
density gradient fractions (1.08–1.14 g/mL density) which co-
expressed the CD63 with classical mesenchymal vesicular
Table 3 Biological pathways
over-represented by the 69
enriched/selected miRNAs of the
medium-density EVs in CF2
fraction (P < 0,01; corrected
FDR)
KEGG pathway p-value #genes #miRNAs
Fatty acid biosynthesis <1e-325 4 5
Fatty acid metabolism <1e-325 12 7
Glioma <1e-325 40 10
Lysine degradation <1e-325 24 16
Hippo signaling pathway <1e-325 89 18
ECM-receptor interaction <1e-325 48 19
TGF-beta signaling pathway <1e-325 59 22
Signaling pathways regulating pluripotency of stem cells <1e-325 100 24
Proteoglycans in cancer <1e-325 128 30
Biosynthesis of unsaturated fatty acids 8.88E-16 9 8
Mucin type O-Glycan biosynthesis 8.65E-11 17 12
Wnt signaling pathway 8.54E-10 43 5
Prion diseases 1.99E-09 2 2
Thyroid hormone signaling pathway 1.56E-08 59 10
Glycosaminoglycan biosynthesis - heparan sulfate / heparin 3.91E-07 9 10
Pathways in cancer 9.90E-07 163 10
Estrogen signaling pathway 2.44E-06 19 6
FoxO signaling pathway 4.67E-06 58 5
Focal adhesion 8.59E-06 54 3
Melanoma 1.84E-05 40 8
Amoebiasis 1.90E-05 24 4
PI3K-Akt signaling pathway 0.0004 74 3
Morphine addiction 0.0005 38 6
Axon guidance 0.0015 61 10
Amphetamine addiction 0.0026 26 6
Prostate cancer 0.0031 16 3
Fig. 6 Heatmap representation of the most significantly enriched
pathways potentially modulated by the selective/enriched miRNAs in
CF2 fraction. Enrichment analysis of the pathways over-represented by
the predicted targets of enriched/selective CF2 miRNAs was conducted
using the software DIANA mirPath. miRNAs with similar patterns in
targeting significant pathways clustered together (69 miRNAs). Strong
correlation with the pathways assembled in metabolic, stem cell
associated- and migration/inflammation processes was observed. Only
pathways targeted by the selected miRNAs with a P-value < 0,01 (FDR
corrected) were considered for the analysis
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markers such as CD29 and ITGA5 [2], and ANXA2 an impor-
tant effector of miRNA recruitment in EVs [38].
The selective expression of miR-451, in the central frac-
tions of the gradient EVs, further supports the enrichment in
exosomes of this fraction, since previous studies in tumor cell
lines showed that this miRNA is preferentially sorted into
exosomes [39].
According to Xu et al. [40], the denser fractions contained
microvesicle-enriched populations. CF3 denser fraction, de-
spite the presence of CD63, does not or barely express the
HLA-1 and ITGA5 suggesting that is a different population
from CF2. Moreover, CF3 is enriched in EVs of larger size
(>200 nm) and showed the highest mean diameter among the
different EV populations, supporting the enrichment in
microvesicles of this fraction. The low-density CF1 fraction
contained an undefined population of EVs, that expressed low
levels of CD29 and ANXA2 and were negative for all the
other markers tested.
Xu et al. demonstrated that exosomes and microvesicles
isolated by differential centrifugation from human colon can-
cer cells, have distinct biological activities, being able to pro-
mote invasiveness at different rating [40]. Moreover, Aliotta
et al. showed that exosomes-enriched and microvesicles-
enriched populations from mouse MSCs, have different ef-
fects when infused into mice, in a model of monocrotaline
induced pulmonary hypertension [41]. The same biological
Fig. 7 Analysis of CF proteome. The protein composition of the CFs
defines their origin and potential activity. (a) Quantification of the total
proteins isolated from EVs derived from different CFs, demonstrating an
enrichment of isolated proteins/EV in CF3 in respect to the other CFs.
Data are expressed as means ±SEM (ng protein/EV) of four different
experiments. ANOVAwith Turkey’s multicomparison test. *P < 0.05 vs
CF1. (b) Panther pathway analysis on the CF proteome shows abundance
of interleukin, inflammation, TGF-β, gonadotropin release hormone
receptor, angiogenesis and Wnt signaling pathways. (c) Distribution of
the 413 proteins compartmentalized in all the CFs in different protein
classes. The CF proteome contained the following class of proteins:
signaling molecules, receptors, defense/immunity proteins, enzymes
and cell adhesion molecules. d David GO-BB overrepresented by the
CF proteome (P < 0,001; FDR 1%). The top ten processes were
associated with regulation of cell proliferation, response to wounding,
enzyme linked receptor protein signaling pathway, inflammatory
response, receptor linked signal transduction, immune response, and
regulation of phosphorylation
238 Stem Cell Rev and Rep (2017) 13:226–243
differences in mouse and human MSC EVs sub-populations
were demonstrated by Wen et al., using a model of marrow
radiation damage [42]. We previously showed the ability of
MSC EVs, to promote proliferation and to protect from apo-
ptosis murine and human renal epithelial tubular cells [2, 43].
These effects were ascribed to a heterogeneous population of
EVs containing both microvesicles and exosomes. We here
demonstrated that different EV fractions separated by discon-
tinuous iodixanol gradient based on their density, display dif-
ferential pro-proliferative and anti-apoptotic activities on re-
cipient renal tubular cells despite they were equally internal-
ized by mTEC. EVs from CF1 and CF2 low and medium-
density fractions induced proliferation on renal tubular cells,
cultured in the absence of serum. However, the CF2 enriched-
exosome population was more effective than the others com-
bined fractions in the protection from apoptosis induced by
hypoxia/reperfusion injury on renal target cells. High-density
EVs in fraction CF3, conceivable containing a microvesicle-
enriched population, did not induce significant protection
from apoptosis and proliferation of renal tubular cells, also
after enhancing the dose of EVs administered.
The activity of EVs has been at least in part ascribed to their
miRNA content [42–45]. A subset of miRNA families, was
specific signature of the biologically active CF2 medium-
density fraction. Some of these miRNAs, such as miR-17-5p
and miR-106a have been described together with miR-21 as
differentially expressed during different phases of renal injury,
being potential biomarkers for AKI [32]. Interestingly, differ-
ent miRNA* sequences were only detected in CF2 fraction,
supporting the potential of exosomes to transfer miRNA* out-
side the cells [14].
Several other miRNAs enriched in CF2 fraction, were re-
ported as protective in the context of AKI including miR-34
[27], miR-125b [31], miR-199a-3p, miR-214 [28] and miR-
127 [29]. miR-21 and miR-29, enhanced in CF2, have been
linked to the modulation of kidney fibrosis [30]. miR-451 se-
lectively present in the central fractions of the gradient, has
been demonstrated to act together with miR-144, in the pro-
tection against IRI in the heart [46]. All the miRNAs analyzed
were reduced in the CF1, supporting a less enrichment of
miRNAs in this fraction.
Enrichment analysis of the pathways over-represented by
the predicted targets of enriched/selective CF2 miRNAs
showed strong correlation with metabolic, stem cell
associated- and migration/inflammation processes. High rep-
resentation of fatty acid biosynthesis and metabolism, Wnt
signaling and pluripotent stem cells regulated-pathways,
ECM-receptor interaction and TGF-β signaling pathway have
been detected. Interestingly, downregulation of fatty acid ox-
idation in tubular cells has been described as a key component
of the pathogenesis of AKI [47]. Moreover, stem cell and
Wnt/β-catenin signaling pathways have been also correlated
with repair processes after ischemic AKI [48].
Proteins are together with RNA, important effectors for the
EVactivity. By protein array, we identified a protein cargo of
413 proteins detected in all the different EV fractions. Cross
match with Vesiclepedia database [49] identified 205 classical
EV proteins detected in all the EV fractions. Proteins of the CF
proteome were mainly incorporated as signaling molecules,
receptors and cell adhesion molecules, recently connected
with the potential therapeutic effects of the microvesicles from
MSCs [50]. Defense/immunity proteins and enzyme
Table 4 DAVID analysis to
determine GO term enrichment
(GOTERM_CC_FAT) for genes
coding for proteins of the CF
proteome (n = 413) (P < 0,01;
FDR 1%)
GO Term Count % PValue Bonferroni FDR
GO:0005615 ~ extracellular space 150 38.66 4.03 E-94 1.04E-91 5.26E-91
GO:0044421 ~ extracellular region part 167 43.04 1.11E-89 2.85E-87 1.45E-86
GO:0005576 ~ extracellular region 226 58.25 4.14E-89 1.06E-86 5.40E-86
GO:0031226 ~ intrinsic to plasma membrane 92 23.71 5.60E-18 1.44E-15 7.31E-15
GO:0005887 ~ integral to plasma membrane 90 23.20 1.41E-17 3.63E-15 1.84E-14
GO:0009986 ~ cell surface 43 11.08 3.29E-15 8.56E-13 4.34E-12
GO:0044459 ~ plasma membrane part 116 29.90 3.79E-11 9.75E-09 4.95E-08
GO:0009897 ~ external side of plasma membrane 24 6.19 7.76E-10 2.00E-07 1.01E-06
GO:0043235 ~ receptor complex 19 4.90 6.19E-09 1.59E-06 8.08E-06
GO:0031012 ~ extracellular matrix 31 7.99 8.64E-08 2.22E-05 1.13E-04
GO:0060205 ~ cytoplasmic membrane-bounded
vesicle lumen
11 2.84 3.96E-07 1.02E-04 5.17E-04
GO:0031983 ~ vesicle lumen 11 2.84 6.18E-07 1.59E-04 8.07E-04
GO:0031093 ~ platelet alpha granule lumen 10 2.58 2.09E-06 5.37E-04 0.002
GO:0005578 ~ proteinaceous extracellular matrix 27 6.96 2.32E-06 5.97E-04 0.003
GO:0005886 ~ plasma membrane 152 39.18 2.62E-06 6.74E-04 0.003
GO:0031091 ~ platelet alpha granule 11 2.84 4.17E-06 0.001 0.005
GO:0030141 ~ secretory granule 19 4.90 5.13E-06 0.001 0.006
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modulators class of proteins were also detected in the CF
proteome. Moreover, they were classified as extracellular,
plasma membrane, matrix and vesicle proteins. Pathway anal-
ysis of the CF proteome reveals high representation of path-
ways such as interleukin mediated signaling and chemokine/
cytokine mediated inflammation, Wnt signaling, TGF-β and
angiogenesis pathways. MSC CF proteome was relevantly
enriched in anti- and pro-inflammatory cytokines.
Moreover, EVs from all CF fractions expressed the
chemokines receptors of cell of origin, such as CXCR1,
CXCR6, CXCR4, CXCR3, CCR3 and CCR7, known to be
involved in the MSC migration to the sites of inflammation
[51]. Eph A4 and different subclasses of the Eph B receptors,
regulators ofMSC attachment/migration [52] and inhibitors of
T cell proliferation [53], were also present in all EV fractions.
Moreover, numerous pro-angiogenic and pro-migratory mol-
ecules such as the soluble factors VEGF, TGF-β, ΙL-8 and
PDGF and PDGFRα/β were compartmentalized in all the
CF fractions. Interestingly, increasing angiogenesis together
with renal blood flow have been recently observed in IRI rats
treated with adipose mesenchymal stem cell exosomes and
associated with the reversion of the kidney damage [54].
The catalytic subunit PI3-Kinase p85-beta, detected among
the 50 major expressed proteins of CF proteome, has been
Table 5 List of proteins over-expressed in CF2 (FC CF2 > 1.5)
List of proteins over-expressed in CF2 in respect to CF3
TIMP2 Thymidine Kinase1 BDNF CCL11 IL1 F6
ALK4 SPINK1 Frizzled6 VEGF R3 Activin B
MCSF R ALCAM PlGF 11bHSD1 betaCatenin
hCG alpha CTGF IL17RC TSLP R TNFRSF12
FGFBP IL3 R alpha HGF Neuropilin2 GPNMB
ACTH Trypsin 1 IGFI FGF R4 IL1 R3
PAI1 OSM CCR8 VWF CXCL16
VEGFC CXCR3 CCR6 S100A6 Leptin (OB)
IL21 R ENA78 IGFBP1 S100A10 CCR1
RAGE MCSF TNFRSF1A TNFRSF11B IFNalpha / beta R1
Resistin IL17R CD56 IL28A LRP6
GDNF CXCR2 IL12 p40 Tissue Factor DANCE
Thrombospondin4 TFPI proGlucagon Gastrin NeuroD1
PLUNC CCR5 Chem R23 BMP2 CCR2
FGF R3 TOPORS NT4 TNFSF8 ApoE3
List of proteins over-expressed in CF2 in respect to CF1
Thrombospondin1 Plasminogen ICAM5 SRMS IL15 R alpha
Fibronectin hCG alpha NeurokininA BCAM BMP2
ApoA4 PTHLP CD14 CCR6 TNFSF8
Factor XIII A CNDP1 ALCAM CCL16 Activin B
Clusterin APC CKMB CD56 betaCatenin
TYRO10 FGFBP HADHA HBEGF IL1 R3
ACK1 CA 153 TNFRSF17 proGlucagon ICAM2
ALPP ACTH TNFRSF5 MMP25 LRP6
Ubiquitin + 1 PAI1 CCR5 ErbB2 DANCE
Btk Cardiotrophin1 Frizzled5 CCL11 NeuroD1
TNFRSF21 VEGFC BDNF Protein p65 IL17C
BAI1 TRKB APJ FAP FGF9
Activin A CEA IFNgamma R1 HSP10 CCR2
SERPINA6 CBP ApoC1 CD80 GLO1
Beta IGH3 IGFBP7 CD117 TNFSF3 PDX1
CA 125 Calcitonin IGFI ErbB3 ApoE3
ABL1 AR IL29 EGF
TIMP2 Thymidine Kinase1 CCR8 Apelin
ALK4 C9 IL1 F5 ADAMTS10
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recently correlated with cell cycle re-entry and proliferation
via PI3K/Akt signaling pathway activation [55].
The protein associated biological processes overrepresent-
ed in CF2, which was the most biologically active fraction,
included positive regulators of proliferation, response to
wounding and cell-cell signaling possibly accounting for the
pro-proliferative activity of CF EVs. Migration/proliferation
processes were also over-represented by the enriched
miRNAs in the medium-density CF2 fraction, showing a col-
laborative pattern of proteins and miRNAs shuttled by MSCs
in promoting regenerative processes. Interestingly, TGF-β
pathway crucial in AKI progression to chronic kidney disease
[56] was overrepresented both by miRNAs and proteins com-
partmentalized in the CF2 fraction, suggesting the regulation
of this pathway by MSC EVs treatment.
Of interest, the major cytokine enriched in CF2 fraction
was the IL-13 that together with IL-10 and IL-4, mediates
differentiation of monocytes in non-inflammatory (M2)
macrophages [57]. Recently, MSCs have shown the ability
to educate macrophages to acquire an anti-inflammatory M2
phenotype, promoting kidney repair in rhabdomyolysis-
induced acute kidney injury [58]. Further, CF2 EVs contained
high levels of ApoC3 and ApoA4, recently detected inside the
EVs produced by umbilical cord blood-derived MSCs with
other family members and involved in inflammation and tis-
sue repair [59].
In conclusion, this study demonstrated that EVs derived
from MSCs are heterogeneous with specific signatures ac-
counting for the biological activity of different EV popula-
tions. Proteins and miRNAs shuttled by MSCs showed a col-
laborative pattern in crucial processes activated after injury,
such as metabolic, stem cell, inflammation/migration and an-
giogenic related processes. Moreover, the medium-density
CF2 fraction containing exosome-enriched population of
EVs showed the best activity in promoting renal protection
from injury in vitro. This fraction was enriched in miRNAs
Fig. 8 Differential expression analysis of proteins in EVs from different
CF fractions. a David GO-MF terms over-represented by the proteins
upregulated in the medium density CF2 in respect to the CF3 high
density fraction (n = 75, FC CF2 > 1.5, outer chart). The same analysis
was conducted for proteins upregulated in CF2 in respect to the low-
density fraction CF1 (n = 92, FC CF2 > 1.5, inner chart). (B-C)
Distribution analysis of the proteins enriched in CF2 in respect to CF3
b and to CF1 c, in different biological processes (GO-BB). The main
representative classes were: signal transduction via receptor interaction,
cell proliferation, response to wounding, cell-cell signaling and
inflammatory response. (P-value < 0,01, FDR 1%)
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and proteins associated with biological processes fundamental
in kidney regeneration.
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